Calviri has been developing an RNA vaccine to prevent cancer for more than 20 years and repeatedly faced the nearly universal belief that it’s impossible. We’ve learned a number of important lessons along the way that are worth imparting to other vaccine developers.
- 6 PEG Alternatives You Should Be Thinking About
- Achieving Flexibility In RNA Drug Manufacturing With Microfluidics
- Modular And Single-use Tech Driving The Future Of Biomanufacturing
- What We Need To Unlock Next-Generation mRNA Therapeutics
- What Regenerative Medicine Manufacturers Have Been Waiting For
- New Developments In mRNA Vaccine Efficacy Show Promise
- FDA Sets Recommendations For Predicting Dangerous Nitrosamine Impurities
- Oh, Oligonucleotides! Everybody Wants In
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Moving CGTx Clinical Development Forward In 2023
Gain insights on cell and gene therapy (CGTx) clinical trial design and commercialization strategies as a panel of industry experts share their considerations.
-
Leveraging Single-Use Technology For mRNA-LNP Drug Manufacturing
Single-use technology is vital for ensuring the quality and expedited market entry of genomic medicines. Learn how LNP technology is paving the way for a new era of personalized, precise medicine.
-
RNA: The Next Era In Therapeutic Development
Review the unique set of challenges for RNA production that must be considered and solved to reach their full therapeutic potential.
-
RNA Therapies – Global Clinical Trial Landscape - Focus On Asia Pacific
Learn about the global clinical trial landscape of RNA therapy, with emphasis on trends in the Asia Pacific, and recent advancements in the field.
-
Fit-For-Purpose Lipids Can Accelerate, Scale, And Improve RNA-LNP Drugs
Emerging biotech companies are investing in novel delivery capabilities to address different modalities' needs and extra-hepatic delivery. Explore steps to accelerate commercial nanomedicine delivery.
-
mRNA Product IVT Process Insights
In vitro transcription (IVT) allows a researcher to tailor synthesis and introduce modifications to produce a transcript. Learn about IVT along with process challenges and strategies.
-
mRNA: How To Build A Custom Program Using CDMO Services
Development of RNA-based therapies sits at the cutting edge of vaccine and oncology innovation, in addition to holding promise in dozens of other therapeutic areas.
-
Purification Of DNA Oligonucleotides Using An Anion Exchange Resin
Learn how a strong anion exchange resin can be used for the efficient purification of single-stranded DNA oligonucleotides used in clinical trials.
-
mRNA-LNP Nucleic Acid Assessment From Distinct Formulations
Review a showcase of a high throughput robust analysis for nucleic acid integrity and size assessment of mRNA-LNP samples using a multi-capillary system and purity and integrity analysis kit.
-
Determining RNA Integrity And Purity By Capillary Gel Electrophoresis
To ensure mRNA product quality, it's important to confirm the integrity of the RNA. Examine the results of a study challenging the performance of the CGE method in assessing mRNA integrity and purity.